It is a pharma private limited company based in Salem, Tamil Nadu, India, established in 2004.
2004 | Salem, Tamil Nadu, India | ActivePrs Pharmaceuticals Private Limited, a active private limited company, was established on 04 October 2004 in Salem, Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231TZ2004PTC011374. Registered under ROC Roc Coimbatore. it is unlisted. It has an authorized capital of ₹1.20 M and a paid-up capital of ₹1.20 M.
It upholds a compliant status. Employing 21 professional, Its leadership includes Rajendran (Director), Sekar Raji (Director), Rajamanickam (Managing Director). Past directors included Perumal Ramar, Rajendran, Mohamedmohideen Hasanmohammed. It holds ₹7.75 M open charges and no settled loans. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at No. 9 Udayar Thottam, Mallamoopampatty,, Salem, Tamil Nadu, 636302.
U24231TZ2004PTC011374
011374
04 October 2004
₹1.20 M
₹1.20 M
Roc Coimbatore
Unlisted
Active
Explore comprehensive insights into Prs Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajendran | Director | 21 Apr 2015 | Current |
| Sekar Raji | Director | 04 Oct 2004 | Current |
| Rajamanickam | Managing Director | 04 Oct 2004 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 02 Feb 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
| Pramod Abcsdd | Director | 01 Jun 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Prs Pharmaceuticals Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 40.26% increase. The company also saw a substantial improvement in profitability, with a 24.02% increase in profit. The company's net worth Soared by an impressive increase of 119.27%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Prs Pharmaceuticals had a promoter holding of 71.67% and a public holding of 28.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹7,747,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jan 2016 | Indian Overseas Bank | ₹5.00 M | Open |
| 09 Oct 2014 | Indian Overseas Bank | ₹2.75 M | Open |
Explore comprehensive loan charge details -
Prs Pharmaceuticals has a workforce of 21 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Prs Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prs Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Prs Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was recorded as a recent event.
The activity Prs Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Coimbatore. was completed.
Progress on A charge with Indian Overseas Bank of Rs. 5.00 M registered on 30 Jan 2016 with Charge ID 10628140 was modified on 08 Jan 2021. was documented.
Progress on A charge with Indian Overseas Bank amounted to Rs. 5.00 M with Charge ID 10628140 was registered on 30 Jan 2016. was documented.
The activity Rajendran was appointed as a Director was appointed as a Director on 21 Apr 2015 & has been associated with this company since 10 years 7 months . was completed.
A charge with Indian Overseas Bank of Rs. 2.75 M registered on 09 Oct 2014 with Charge ID 10533176 was modified on 17 Oct 2014. was recorded as a recent event.
The CIN of Prs Pharmaceuticals Private Limited is U24231TZ2004PTC011374.
Prs Pharmaceuticals Private Limited is headquartered at No. 9 Udayar Thottam, Mallamoopampatty,, Salem, Tamil Nadu, 636302.
Prs Pharmaceuticals Private Limited was incorporated on 04 October 2004.
The current directors of Prs Pharmaceuticals Private Limited are
The primary industry of Prs Pharmaceuticals Private Limited is Manufacturing.
Prs Pharmaceuticals Private Limited is unlisted.
The authorized capital of Prs Pharmaceuticals Private Limited is ₹1.20 M, and the paid-up capital is ₹1.20 M.
The compliance status of Prs Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX